home.social

#melanoma — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #melanoma, aggregated by home.social.

  1. New #mRNA #Vaccine Could Prevent #SkinCancer From Returning
    #Moderna and #Merck say experimental vaccine prevented return and spread of #cancer in high-risk #melanoma patients.
    mRNA tech was instrumental in rapid vaccine development in the Covid-19 pandemic added a new element of speed and flexibility to quest for therapeutic cancer vaccines. Scientists can use mRNA platform to create bespoke, individualized vaccines matching genetics of tumors.
    nytimes.com/2026/08/19/science
    archive.ph/mqJBi

  2. He convertido una versión editada de esta entrada en mi blog en @naukas_com en un nuevo artículo para @Conversation_E Para entender de forma sencilla en qué consiste la innovadora vacuna/terapia dual contra el #melanoma : anticuerpos monoclonales y ARNm
    theconversation.com/asi-funcio

  3. ¿Quieres saber cómo la tecnología ARN puede usarse contra el cáncer? Te cuento, de forma sencilla, en mi blog #gen_ética en @naukas_com en qué consiste el componente #ARNm de la nueva terapia contra el #melanoma desarrollada por las empresas MSD y Moderna.
    montoliu.naukas.com/2026/08/23

  4. #antivaxxer #melanoma
    Yup … they’ll be all anti-vax until they hear about treatments like this … and then it’s “where do I get this shot 💉 ?”

  5. ➕ Nola funtzionatzen dute #RNA mezularia bidezko txertoek?

    Hemen COVID-19aren kontrako txertoak sortu zirenean #Elhuyar aldizkarian landutako erreportajea: zientzia.eus/artikuluak/rna-me

    #Melanoma ren kasuan, antzera funtzionatzen du: lehendik melanoma izan eta kirurgia egin zaien pazienteei berariazko erantzuna sorrarazten dute.

    Saio klinikoen III fasea baimena jaso aurrekoa da.

  6. #Melanoma ren kontrako txertoa iragarri dute Merck eta Moderna konpainia farmazeutikoek. #RNAm teknologian oinarrituta dago, eta saio klinikoen III fasea gainditzea lortu du.

    Iragarpena denean zabaldu da, eta bi konpainiek gorakada nabarmena izan dute burtsan.

    Oraindik ez dute ikerketa argitaratu, eta sendagaien agentziek ere ez dute aztertu. Jarraipena egingo diogu, itxaropentsu baina zuhurtziaz

  7. In August, #RFKJr’s #HHS followed up by announcing it would no longer fund #mRNA #research through the Biomedical Advanced Research & Development Authority. The latter move involved the cancellation of 22‼️ separate contracts.

    After the #FDA initially declined to review #Moderna’s mRNA-based #flu #vaccine because of the design of the company’s clinical trial, the agency recently approved it.

    #Melanoma #cancer #vaccine #PublicHealth #health #science #medicine #MedicalBreakthrough

  8. Experts say major safety concerns are unfounded, but #government #funding for #mRNA, particularly for its use against respiratory viruses, has been slashed during #Trump’s 2nd admin, driving concerns that mRNA innovation could stall.

    #RFKJr’s #HHS last year CANCELLED a $590 million deal with #Moderna to develop an mRNA-based #vaccine against emerging pandemic influenza.

    #Melanoma #cancer #PublicHealth #health #science #medicine #MedicalBreakthrough

  9. Messenger RNA, or #mRNA, is a single-stranded molecule that delivers genetic information to direct the formation of proteins. Before it was used in #vaccines against #Covid19, mRNA was stirring excitement among #cancer researchers.

    However, the technology has faced backlash in the wake of the pandemic, with some [ #ConspiracyTheories ] questioning the safety of mRNA.

    #Melanoma #vaccine #PublicHealth #health #science #medicine #MedicalBreakthrough

  10. Karen Knudsen, CEO of the Parker Institute for #Cancer ⁠Immunotherapy, said the Moderna results could signal a new era for treating solid-tumor #cancers.

    “The positive hit here leads us into truly this next phase in #immunotherapy,” Knudsen said. “This is an auspicious start — this is where things begin.”

    #Melanoma #vaccine #PublicHealth #health #science #medicine #MedicalBreakthrough

  11. In January, the companies announced results of a mid-stage trial of the treatment showing ⁠that it reduced the risk of recurrence or death by 49% after 5 years.

    #Melanoma is the deadliest form of skin #cancer. In 2023, there were >1.5 million people in the US living with melanoma, acc/to the National Cancer Institute.

    The companies said they will present their results at an upcoming medical meeting & share them ⁠with regulators.

    #PublicHealth #health #science #medicine #MedicalBreakthrough

  12. The trial enrolled 1,137 high-risk patients with stage 2b to 4 #melanoma that had been surgically removed.

    Volunteers were randomized to receive up to 9 doses of #Keytruda plus ⁠the personalized #vaccine or Keytruda alone for about one year. The companies said no new safety signals have emerged in the trial. Previous studies showed the most common side effects were fatigue, pain at the injection site & chills [better than dying!].

    #PublicHealth #health #science #medicine #MedicalBreakthrough

  13. “For many years, the idea of creating an #mRNA treatment designed specifically for an individual patient’s #cancer was aspirational,” Bancel said in a statement. “We are now helping turn that vision into a reality.”

    The cancer ‌treatment ⁠combines Keytruda with a made-to-order mRNA #vaccine that is based on an analysis of mutations found in the patients’ own tumors.

    #melanoma #PublicHealth #health #science #medicine #MedicalBreakthrough

  14. A personalized #mRNA #cancer #vaccine combined with the #immunotherapy #Keytruda succeeded in a late-stage trial for the deadly skin cancer #melanoma, its makers said Wednesday, potentially opening up a new way of treating the #disease.

    The study is ongoing, but interim results found the treatment, #intismeran, met both its primary target of reducing cancer recurrence & its secondary ⁠goal of keeping cancers from spreading to other parts of the body.

    #PublicHealth #health #science #medicine

  15. [The Wall Street Journal-Gifted article]: Moderna Shares Double on Success of mRNA Cancer Vaccine

    Result from Merck-Moderna partnership validates years of research into mRNA-based therapeutic cancer vaccines. By Xavier Martinez and Alex Janin, August 19, 2026.

    wsj.com/health/pharma/moderna-

    #melanoma #cancer #moderna

  16. 💁🏻‍♀️ TIL: 🧬💉 #Tattoo ink triggers an immune response the moment it enters the skin, with pigment particles lodging permanently in the dermis and sometimes traveling to #lymphnodes.

    A medical microbiologist explains that many modern inks contain industrial pigments and heavy metals, and the largely unregulated industry leaves consumers to navigate risks on their own.

    👉 sciencealert.com/were-only-jus

    #tattoos #immunesystem #health #science #skincancer #melanoma #allergies #research #bodyart #art #microbiology